- Cellectar Biosciences ( NASDAQ: CLRB ) said it is implementing a consolidation (reverse stock split) of its outstanding Common Shares on the basis of one new Common Share for every 10 currently outstanding.
- As of Thursday, the company will have about 6.1M shares outstanding.
- The new common shares will be effective for trading purposes as of the commencement of trading on Friday, July 22, and will trade under CUSIP number 15117F807.
- Stockholders who would otherwise hold a fractional share will receive a cash payment in lieu of the fractional share.
For further details see:
Cellectar announces reverse stock split